fda restrictions bpc-157 compounding NBC News | The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger-looking skin, FDA's own advisory committee voted
FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them Big win for $HIMS. The FDA advisory panel voted to allow compounding of BPC 157, KPV, TB 500 and MOTS C, opening the door to a multibillion dollar peptide market. Hims is positioned to capitalize. FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr. MedPage Today Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Is BPC 157 Legal in 2026? FDA Compounding Status Explained
Pay in 4 interest-free payments of $7.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



